CONTAK RENEWAL® Heart Failure Heart Rate Variability Registry

Boston Scientific Corporation0 个研究点目标入组 1,400 人开始时间: 2003年2月最近更新: 2006年11月14日

适应症

试验速览

The Registry will evaluate how HRV Monitor diagnostics change after cardiac resynchronization therapy in patients with heart failure.

•Patients receiving their first CRT-D
•Patients who sign and date a Patient Informed Consent prior to device implant
•Patients who are available and willing to attend follow-up visits at the study center in which they were enrolled

•Patients who are anticipated to receive pacing modes other than DDD or VDD (i.e., chronic atrial fibrillation patients are excluded), or patients who are anticipated to receive adaptive rate therapy
•Patients who are younger than 18 years of age
•Patients whose life expectancy is less than six-months due to other medical conditions
•Patients with or who are likely to receive a tricuspid or other valve prosthesis
•Patients who are currently enrolled in another investigational study that would directly impact the treatment or outcome of the current study
•Women who are pregnant

发起方

申办方类型

Industry